Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 913-635-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
No test has been performed on the reaction mass itself. However acute toxicity data are available on the two components of this reaction mass for oral and dermal routes. The acute toxicity of the two components is low for these two routes of exposure. Therefore the acute toxicity of the reaction mass is considered also to be low.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1960
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: This study was conducted prior to GLP and test guidelines.
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Rats (2 per dose) were exposed (single exposure) to 3980 mg/kg of sodium chloride (administrated as 20% water solution). Mortality and gross pathology were observed.
- GLP compliance:
- no
- Test type:
- other: The test was conducted prior to GLP and test guidelines.
- Limit test:
- yes
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- No data
- Route of administration:
- oral: unspecified
- Vehicle:
- water
- Details on oral exposure:
- Rats were fed 20% solution of Cubidow (sodium chloride) in water at the dose of 3.98 g/kg.
- Doses:
- 3.98 g/kg (20% solution in water)
- No. of animals per sex per dose:
- 2
- Control animals:
- not specified
- Details on study design:
- no data
- Statistics:
- no data
- Preliminary study:
- No data
- Key result
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 3 980 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: The LD50 value was for 20% solution of cubidow in water
- Mortality:
- No mortality
- Clinical signs:
- other: No data
- Gross pathology:
- Extensive liver and kidney damage were observed at autopsy. No serious untoward reactions were observed.
- Other findings:
- No ne
- Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- Cubidow has low acute oral toxicity. LD50 for 20% solution of cubidow in water is greater than 3980 mg/kgbw.
- Executive summary:
Cubidow has low acute oral toxicity. LD50 for 20% solution of cubidow in water is greater than 3980 mg/kgbw.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- not specified in the report
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The report contains sufficient information to permit a meaningful evaluation of study results
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- The study methodology followed appeared to be similar to the standard acute method.
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- not specified
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- not specified in the report
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 25% concentration (water solution) - Doses:
- 2150, 3160, 4640 and 6810 mg/kg
- No. of animals per sex per dose:
- 5 male rats/dose
- Control animals:
- not specified
- Details on study design:
- not specified in the report
- Statistics:
- not specified in the report
- Preliminary study:
- not applicable
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 3 550 mg/kg bw
- Based on:
- test mat.
- Mortality:
- Cummulative mortality -
2150 mg/kg - 0/5
3160 mg/kg - 1/5
4640 mg/kg - 5/5
6810 mg/kg - 5/5 - Clinical signs:
- other: Hypoactivity, muscular weakness, sedation and ruffled fur
- Gross pathology:
- No significant findings noted in those animals sacrified at termination and inflammation of gastrointestinal tract was noted in those decedents during the course of the study
- Other findings:
- not specified in the report
- Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- The acute oral LD50 of sodium chloride (administered as 25% water solution) was 3550 mg/kg to male rats and based on the results; sodium chloride is not classified for oral acute toxicity according to EU GHS criteria (CLP Regulation). According to UN GHS criteria, sodium chloride should be classified Acute. Tox. Cat. 5, H303: May be harmful if swallowed.
- Executive summary:
In this study, the acute oral LD50 of sodium chloride was evaluated in male Wistar rats at doses of 2150, 3160, 4640 and 6810 mg/kg, adminsitered as a 25% water solution. 100% mortality was observed at the 4640 and 6810 mg/kg dose groups. The LD50 was 3550 mg/kg with fiducial limits of 3040 -4140 mg/kg. Based on these results sodium chloride is not classified for oral acute toxicity according to EU GHS (CLP Regulation).
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: GLP-compliant guideline study, minor restrictions in reporting (lacking information on test substance purity), but otherwise acceptable for assessment.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Limited, Margate, England
- Weight at study initiation: males 107-127 g, females 106-121 g
- Fasting period before study: overnight
- Housing: in groups of 5, by sex, in grid bottomed popypropylene cages
- Diet: pelleted diet (SQC Rat and Mouse Maintenance Diet No. 1, Expanded, Special Diets Services Limited, Witham, England), as libitum
- Water (e.g. ad libitum): Mains tap water, in polypropylene bottles, ad libitum
- Acclimation period: 12 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21-24
- Humidity (%): 34-68, except one occasion when it rose to 75%
- Photoperiod (hrs dark / hrs light): 12/12
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Amount of vehicle (if gavage): 10 ml/kg bw
DOSAGE PREPARATION (if unusual): the test article was formulated freshly on the day of use in distilled water. For each dose level separately, a weighed amount of test article was made up to the required final volume. Preparations were mixed thoroughly by use of a pestle and mortar before use and shaking during use - Doses:
- In the range-finding study: 2000, 2800, 3920, 5490 and 7680 mg/kg bw
In the main study: 2000, 2800 and 3920 mg/kg bw - No. of animals per sex per dose:
- In the range-finding study: 2/sex/dose
In the main study: 5/sex/dose - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: animals were observed continuously for the first 30 min after dosing and then 1, 2 and 4 hours after dose administration on day 1. Subsequently, animals were observed at least once daily for all visible signs of reaction to treatment and twice daily for mortality and morbidity. Animals were weighed on days 1, 8 and 15 of the sutdy. In addition, decedent animals were weighed at necropsy.
- Necropsy of survivors performed: yes - Statistics:
- The acute oral median lethal dose and 95% fiducial limits were calculated using a probit method (Finney, D. J. (1964), Statistical Methods for Biological Assay, 2nd Edition, London, Charles Griffin). Values were calculated for each sex separately and also for combined male and female animals.
- Preliminary study:
- All animals dosed 2000 mg/kg bw survived. One out of 2 animals of each sex dosed at 2800 mg/kg bw died. Dose levels of 3920 and 7860 mg/kg bw caused death.
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 2 120 mg/kg bw
- Based on:
- test mat.
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 2 361 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 1 518 - <= 3 191
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2 301 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 1 455 - <= 2 781
- Mortality:
- 2000 mg/kg bw: 2 males and one female were found dead on day 2 of the study.
2800 mg/kg bw: one male died on the day of dosing. Two males and 4 females were found dead on day 2 of the study, during which a further male died.
3920 mg/kg bw: one male died within one hour of dosing, a futher male died within 4 hours. Two males and 3 females were found dead on day 1 of the study after the 4 hour observation time. The remaining two females were found dead on day 2. - Clinical signs:
- other: 2000 mg/lg bw: all animals showed lethargy, incoordination and piloerection on day 1 between 1 and 4 hours after dosing. In addition, hunced posture was seen in 4 females and excessive salivation in one male. Clinical signs observed on day 2 were piloerec
- Gross pathology:
- Pale and inflated lungs, reddened and thickened stomach mucosa with rugae absent, reddened mucosa with jejenum and fluid distension of the gastro-intestinal tract were observed at necropsy in decedents. The incidence of these increased with increasing dose level. In addition, red fluid contents were seen in one animal dosed 3920 mg/kg bw. An accetuated lobular pattern was seen in the livers of one animal dosed 2800 mg/kg bw and 3 dosed 3920 mg/kg bw.
In 4 animals examined at terminal necropsy the liver was pale, the stomach showed adhesions to the liver and had a thickened mucosa. In 2 animals the stomach contents were gelatinous. - Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- Based on the LD50 identified in this study: LD50 (male rats) = 2120 mg/kg.bw; LD50 (females rats)= 2361 mg/kg.bw ; LD50 (combined) = 2301 mg/kg.bw, calcium chloride has a low acute toxicity and it is not classified for this endpoint according to EU GHS criteria (CLP Regulation). According to UN GHS criteria calcium chloride should be classified Acute Tox. Cat. 5, H303: May be harmful if swallowed.
- Executive summary:
In this study performed according to the OECD guideline 401, Crj:CD(SD) male and female rats have been exposed by gavage at different doses of calcium chloride (2000, 2800 and 2920 mg/kg. bw). The LD50 are the following: LD50 (males) = 2120 mg/kg.bw ; LD50 (females) = 2361 mg/kg.bw and LD50 (combined) = 2301 mg/kg.bw. Based on these results the acute toxicity of calcium chloride is low and no classification is required according to EU GHS criteria.
Referenceopen allclose all
None
not applicable
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 120 mg/kg bw
- Quality of whole database:
- Two reports with reliability 2 are available on sodium chloride, one component of the reaction mass. In the first report the LD50 in male rats (25% water solution) was 2550 mg/kg.bw. In the second study the LD50 was greater than 3980 mg/kg.bw (20% water solution). For calcium chloride, the second component of the reaction mass a report is also available with reliability 2. The lower LD50 was identified for male rats and was 2120 mg/kg.bw. The acute toxicity by oral route of the two components of the reaction mass is similar (LD50 = 2550 mg/kg.bw for sodium chloride compared to LD50 = 2120 mg/kg. bw. for calcium chloride) and considered to be low. Therefore the oral acute toxicity of the reaction mass itself is also considered to be low.
In a worst case approach and considering that the composition of the reaction mass is 68% of calcium chloride and 30% of sodium chloride, the LD50 of calcium chloride (2120 mg/kg.bw) (lower value) is retained for the reaction mass.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Data waiving:
- other justification
- Justification for data waiving:
- the study does not need to be conducted because exposure of humans via inhalation is not likely taking into account the vapour pressure of the substance and/or the possibility of exposure to aerosols, particles or droplets of an inhalable size
- other:
- Endpoint:
- acute toxicity: inhalation
- Data waiving:
- other justification
- Justification for data waiving:
- the study does not need to be conducted because exposure of humans via inhalation is not likely taking into account the vapour pressure of the substance and/or the possibility of exposure to aerosols, particles or droplets of an inhalable size
- other:
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Quality of whole database:
- Since data are available for the two other routes of exposure (oral and dermal routes) a waiving was done for inhalation.
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study report that meets generally accepted scientific principles.
- Principles of method if other than guideline:
- Method: other
- GLP compliance:
- no
- Limit test:
- no
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Type of coverage:
- occlusive
- Vehicle:
- water
- Duration of exposure:
- 24 hours
- Doses:
- 5000 mg/kg
- No. of animals per sex per dose:
- 2
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- no mortality
- Clinical signs:
- other: no adverse effects
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Based on this study the LD50 for dermal route in rabbits is higher than 5000 mg/kg.bw. Therefore according to EU and UN GHS criteria no classification is required for dermal acute toxicity.
- Executive summary:
In this study males and females New Zealand rabbits were exposed dermally during 24 hours to 5000 mg/kg.bw of undiluted calcium chloride. No mortality occurred. Calcium chloride has a very low dermal acute toxicity and no classification is required according to EU and UN GHS criteria.
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The report contains sufficient information to permit a meaningful evaluation of study results
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- The study methology followed appeared to be equivalent or similar to the standard acute method
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- not specified in the report
- Type of coverage:
- not specified
- Vehicle:
- water
- Details on dermal exposure:
- Sodium chloride was moistened with sufficient water to make a paste
- Duration of exposure:
- not specified in the report
- Doses:
- 10000 mg/kg
- No. of animals per sex per dose:
- 5 rabbits
- Control animals:
- not specified
- Details on study design:
- not specified in the report
- Statistics:
- not specified in the report
- Preliminary study:
- not applicable
- Key result
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 10 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- no mortality was observed
- Clinical signs:
- other: no signs of toxicity observed
- Gross pathology:
- no significant findings were noted at necropsy
- Other findings:
- slight erythema was observed
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Based on the results of the study, sodium chloride is not classified according to EU and UN criteria since the LD50 in rabbits is higher than 10000 mg/kg.bw.
- Executive summary:
A dermal toxicity study was conducted in rabbits and the LD50 value was greater than 10000 mg/kg and hence not classified according to EU and UN GHS criteria.
Referenceopen allclose all
The dermal LD50 was >5000 mg/kg. All four rabbits topically treated with the test material survived. No adverse effects were observed following treatment. Topical responses observed on the application sites of test rabbits 24 hours post-treatment included slight (1/4) or moderate (3/4) redness, moderate (3/4) or marked (1/4) swelling and moderate (2/4) or marked (2/4) necrosis. Gross necropsy examination of rabbits 2 weeks post-treatment revealed skin lesions at or near the site of administration, characterized by scab formation, skin thickening and subchronic inflammation. Internal observations were not considered to be the result of compound exposure and/or absorption.
not applicable
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- One report, 1981 with reliability 2 is available on calcium chloride, one component of the reaction mass. A dermal LD50 higher than 5000 mg/kg.bw was identified for male and female rabbits. The dermal LD50 calculated for sodium chloride, the second component of the reaction mass, based on a report with reliability 2 is higher than 10000 mg/kg.bw. Based on available data the two components of the reaction mass have similar acute dermal toxicity (low acute toxicity). Therefore the acute dermal toxicity of the reaction mass is considered also to be low.
In a worst case approach and considering that the composition of the reaction mass is 68% of calcium chloride and 30% of sodium chloride, the LD50 of calcium chloride (higher than 5000 mg/kg.bw) (Lower value) is retained for the reaction mass.
Additional information
Justification for classification or non-classification
Based on the data on the two components (calcium chloride and sodium chloride) the reaction mass has a low acute toxicity by oral and dermal routes and no classification is required according to EU GHS criteria.
-The oral LD50 is considered in a worst case approach to be equal to 2120 mg/kg.bw
- The dermal LD50 is considered in a worst case approach to be greater than 5000 mg/kg.bw
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.